(P55.8) Other haemolytic diseases of fetus and newborn

More details coming soon

Icon
747 925 in individuals diagnosis other haemolytic diseases of fetus and newborn confirmed
Icon
1 731 deaths with diagnosis other haemolytic diseases of fetus and newborn

Diagnosis other haemolytic diseases of fetus and newborn is diagnosed Women are 3.07% more likely than Men

362 484

Men receive the diagnosis other haemolytic diseases of fetus and newborn

660 (0.2 %)

Died from this diagnosis.

100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
385 441

Women receive the diagnosis other haemolytic diseases of fetus and newborn

1 071 (0.3 %)

Died from this diagnosis.

Risk Group for the Disease other haemolytic diseases of fetus and newborn - Men and Women aged 0

Icon
In Men diagnosis is most often set at age 0-5
Icon
Less common in men the disease occurs at Age 5-95+Less common in women the disease occurs at Age 0-95+
Icon
In Women diagnosis is most often set at age 0-1

Disease Features other haemolytic diseases of fetus and newborn

Icon
Absence or low individual and public risk
Icon

Other haemolytic diseases of fetus and newborn - what does this mean

Other haemolytic diseases of the fetus and newborn are caused by antibodies produced by the mother that cross the placenta and attack the fetus's red blood cells, leading to haemolytic anaemia and other complications. these diseases can be caused by a variety of different antibodies, including those to rh, kell, duffy, kidd, and mns blood group antigens. treatment may involve blood transfusions, exchange transfusions, or other supportive care.

What happens during the disease - other haemolytic diseases of fetus and newborn

Other haemolytic diseases of the fetus and newborn are caused by a variety of inherited or acquired defects in the red blood cells, which can lead to hemolysis and anemia. these defects can be due to genetic mutations, autoimmune processes, infections, or exposure to certain drugs or toxins. in some cases, the cause is unknown. the hemolysis can occur in the uterus, during delivery, or after birth, and can lead to severe anemia, jaundice, and other complications. treatment depends on the underlying cause and may include blood transfusions, antibiotics, or other medications.

Clinical Pattern

More details coming soon

How does a doctor diagnose

  • Complete Blood Count (CBC) and Blood Smear
  • Liver Function Tests
  • Haptoglobin Test
  • Direct Coombs Test
  • Indirect Coombs Test
  • Osmotic Fragility Test
  • Glycophorin A Test
  • G6PD Test
  • Pyruvate Kinase Test
  • Hemoglobin Electrophoresis
  • DNA Testing
  • Ultrasound
  • Amniocentesis
  • Chorionic Villus Sampling

Treatment and Medical Assistance

Main goal of the treatment: To reduce the risk of haemolytic diseases of fetus and newborn.
  • Identify any underlying causes of the disease, such as genetic or environmental factors.
  • Provide supportive care, such as oxygen, nutrition, and fluids.
  • Administer medications and treatments, such as antibiotics, antifungal drugs, and blood transfusions.
  • Monitor the condition of the newborn and fetus with regular tests and scans.
  • Provide counseling and support for the family.
  • Refer the patient to a specialist, if necessary.
Icon
11 Days of Hospitalization Required
Icon
Average Time for Outpatient Care Not Established

Other haemolytic diseases of fetus and newborn - Prevention

The best way to prevent other haemolytic diseases of the fetus and newborn is to ensure that the mother receives adequate prenatal care, including regular blood tests to monitor for any signs of the disease. additionally, it is important for the mother to receive regular vaccinations to protect against infections that can cause haemolytic diseases.